INNOVATIVE SOLUTIONS
FROM CONCEPT TO FINISHED PRODUCT
AREAS OF FOCUS
Vascular Technologies
Lyophilization Contracting
Peptide Bioscience
ABOUT ATTWILL MEDICAL
ATTWILL Medical Solutions operates across three divisions:
       1. Contract Lyophilization Manufacturing
       2. Vascular Technologies
       3. Peptide Bioscience

ATTWILL meets our customer’s outsourcing needs for medical devices, pharmaceuticals, nutraceuticals and reagents. We design products and offer contract manufacturing services that can improve quality of life. We offer excellence in end-to-end product solutions involving lyophilization. Our state-of-the-art facility provides flexible manufacturing in a controlled environment

ATTWILL uses the same cGMP, ISO standards and manufacturing facilities for its’ innovative and patented ATTWILL-branded products in the fields of Vascular Access and Peptide Biosciences. Our team of product development, research and development, regulatory and quality assurance professionals work closely with you to innovate and meet specific project requirements.
ATWILL NEWS
Read Full Article
Attwill Receives FDA 510k Clearance for HaloGUARDTM
ATTWILL Medical Solutions [ATTWILL] is pleased to disclose that its HaloGUARDTM product has received FDA 510(k) clearance in September 2020.
Read Full Article
Operation Warp Speed participant, Vaxart, Inc. (NASDAQ: "VXRT") Signs MOU with AMS for Production of COVID-19 Vaccine
Enabling Production Through Large Scale Lyophilization, Tableting and Coating
Read Full Article
Attwill announces the completion of it's acquisition of the assets of Anteco Pharma LCC
ATTWILL VASCULAR TECHNOLOGIES LP, ANNOUNCES THE COMPLETION ITS ACQUISITION OF ANTECO PHARMA LLC
Read Full Article
Attwill announces licensing deal.
ATTWILL Medical Solutions is pleased to announce that it has entered into a license deal with a major medical vascular device company for restricted uses of Anti-thrombin....
Read Full Article
Pending Publication
PCT filings for insert for Luer connector(US 14/238,416) due for publication October 2015.
Read Full Article
Attwill acquires provisional patent!
Provisional Patent application for Medical devices, systems, and methods utilizing Antithrombin-Heparin compositions.(62174308)